The spectrum of serious infections among patients receiving immune checkpoint blockade for the treatment of melanoma Journal Article

   


Authors: Del Castillo, M.; Romero, F. A.; Argüello, E.; Kyi, C.; Postow, M. A.; Redelman-Sidi, G.
Article Title: The spectrum of serious infections among patients receiving immune checkpoint blockade for the treatment of melanoma
Abstract: The risk of infection among patients receiving immune checkpoint blockade is unknown. We retrospectively reviewed medical records of 740 patients with melanoma who received immune checkpoint blockers. Serious infection occurred in 54 patients (7.3%). The main risk factors were receipt of corticosteroids and/or infliximab. © The Author 2016. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved.
Keywords: melanoma; infection; immunotherapy; checkpoint blockade
Journal Title: Clinical Infectious Diseases
Volume: 63
Issue: 11
ISSN: 1058-4838
Publisher: Oxford University Press  
Date Published: 2016-12-01
Start Page: 1490
End Page: 1493
Language: English
DOI: 10.1093/cid/ciw539
PROVIDER: scopus
PMCID: PMC5106605
PUBMED: 27501841
DOI/URL:

https://www.scopus.com/inward/record.uri?eid=2-s2.0-85014932328&doi=10.1093%2fcid%2fciw539&partnerID=40&md5=24911ee2634319f961dd34304b47b66b
Notes: Article -- Export Date: 3 April 2017 -- Source: Scopus
Altmetric
What is Altmetric?
Citation Impact
What is Dimensions Citation Badge?
BMJ Impact Analytics
MSK Authors
  1. Michael Andrew Postow
    361 Postow
  2. Gil Redelman-Sidi
    30 Redelman-Sidi
  3. Esther Sofia Arguello Perez
    5 Arguello Perez
  4. Fabian Andres Romero
    5 Romero
Related MSK Work